Its worth being clear-eyed about the studys limits: it was a single-center, retrospective chart review, not a randomized trial, and nearly a third of patients discontinued the medication, most often due to gastrointestinal side effects
Patient preference: Some people are more comfortable with daily routines or are uneasy about having a medication active in their system for a full week
With AOD9604, you dont have to worry about hypercholesterolemia as well
Beyond diabetes and obesity, research is now underway to explore the potential of GLP-1 agonists for other conditions like kidney disease, heart failure, Alzheimers, Parkinsons, sleep apnea and drug addiction, she said
( Epub 2019/04/21 )
Studies indicate various ways in which IFN- triggers PD-L1 expression across different tumor types